The cystic fibrosis transmembrane conductance regulator (CFTR) plays a crucial role in regulating fluid secretion by the airways, intestines, sweat glands, and other epithelial tissues. It is well-established that the CFTR is a cAMP-activated, nucleotide-dependent anion channel, but additional functions are often attributed to it, including regulation of the epithelial sodium channel (ENaC). The absence of CFTR-dependent ENaC inhibition and the resulting sodium hyperabsorption were postulated to be a major electrolyte transport abnormality in cystic fibrosis (CF) epithelia. Several ex vivo studies, including those that used the Xenopus oocyte expression system, have reported ENaC inhibition by activated CFTR, but contradictory results have also been obtained. Because CFTR-ENaC interactions have important implications in the pathogenesis of CF, the present investigation was undertaken by our three independent laboratories to resolve whether CFTR regulates ENaC in oocytes and to clarify potential sources of previously-reported dissimilar observations. Using different experimental protocols and a wide range of channel expression levels, we found no evidence that activated CFTR regulates ENaC when oocyte membrane potential was carefully clamped. We determined that an apparent CFTR-dependent ENaC inhibition could be observed when resistance in series with the oocyte membrane was not low enough or the feedback voltage gain was not high enough. We suggest that the inhibitory effect of CFTR on ENaC reported in some earlier oocyte studies could be attributed to problems arising from high levels of channel expression and suboptimal recording conditions, i.e. large series resistance and/or insufficient feedback voltage gain.
Introduction
The primary function of the cystic fibrosis transmembrane conductance regulator (CFTR) is to mediate cAMP-activated anion (Cl -) conductance across the apical membrane of epithelial cells (Anderson et al., 1991; Nagel et al., 1992; Riordan, 1993; Gadsby et al., 1995; Quinton, 1999; Sheppard and Welsh, 1999; Dawson et al., 1999; Gadsby and Nairn, 1999; Nagel, 1999; Akabas, 2000) . Consistent with its Cl -channel function, disease-causing mutations in the CFTR gene result in impaired transepithelial Cl -conductance, a hallmark of cystic fibrosis (CF) (Stutts and Boucher, 1999; Pilewski and Frizzell, 1999; Quinton, 1999) . However, additional functions have been attributed to the CFTR, including regulation of the epithelial Na + channel (ENaC) in airways and sweat glands (Stutts et al., 1995; Stutts et al., 1997; Reddy et al., 1999; Reddy and Quinton, 2003) , regulation of the outwardly-rectifying Cl -channel (Schwiebert et al., 1995; Schwiebert et al., 1999) , calcium-activated Cl -channel (Kunzelmann et al., 1997; Tarran et al., 2002) , ROMK2 potassium channel (McNicholas et al., 1997) ; vesicle trafficking (Bradbury et al., 1992) , regulation of bicarbonate transport (Ko et al., 2002; Park et al., 2002 ) and the expression of inflammatory mediators (Donaldson and Boucher, 2003) . These additional functions of the CFTR remain the subject of intense research and debate, while some earlier claims, such as CFTR-mediated ATP release (Reisin et al., 1994) or acidification of intracellular organelles (Barasch et al., 1991) , have been questioned by later studies (Reddy et al., 1996; Bradbury, 1999) .
Abnormal Na + transport by CF airway epithelia has been suggested by many in vivo and in vitro observations in humans and mice, showing increased amiloride-sensitive transepithelial potentials in CF (Knowles et al., 1981; Knowles et al., 1983; Boucher et al., 1986; Grubb et al., 1994; Mall et al., 1998) , reviewed in (Stutts and Boucher, 1999) . The simplest interpretation of these early observations was that the rate of Na + absorption was increased in CF, thereby explaining the dehydration of the airway surface liquid layer and the impaired clearance of pathogens. Na + hyperabsorption was subsequently attributed to the absence of CFTR in the plasma membrane and to the lack of CFTR-dependent tonic inhibition of ENaC (Stutts et al., 1995; Stutts et al., 1997) . According to this hypothesis, loss of regulatory functions of CFTR is central to the development of CF pathology in the lungs. It is, however, well-established for human reabsorptive sweat ducts, where both the CFTR and the ENaC reside in the same apical membrane, that absence of the CFTR in CF-affected ducts does not elevate Na + conductance (Bijman and Fromter, 1986) , but under certain conditions may even significantly reduce it (Reddy et al., 1999; Reddy and Quinton, 2003) . A direct relationship between ENaC and CFTR conductances in sweat ducts may not necessitate regulatory protein-protein interaction. As pointed out previously by Nagel et al. (2001b) and Horisberger (2003) , due to an imposed Na + concentration gradient in those experiments, at least part of the Na + conductance reduction in CF sweat ducts (Reddy et al., 1999) can arise from voltage-dependence of ENaC conductance, as predicted by the Goldmann-Hodgkin-Katz equation (Hodgkin and Katz, 1949; Hille, 1992) .
Because CFTR activation induces a large voltage shift, Na + current is then measured at a voltage where ENaC conductance is elevated (Nagel et al., 2001b) . These observations in sweat glands are consistent with several studies in mouse lungs. First, Barbry and Lazdunski (1996) reviewed several animal models describing CFTR inactivation and no alteration of ion transport capacities in mouse airways. Second, Fang et al. (2002) identified the role played by the CFTR in the distal airspaces of the lung after stimulation of the cAMP cascade. Importantly, these authors clearly demonstrated that the presence or absence of functional CFTR did not affect basal lung liquid clearance, suggesting that the CFTR has no influence on ENaC activity in that tissue.
ENaC-CFTR interactions have been directly tested in several heterologous expression systems (Stutts et al., 1995; Stutts et al., 1997) . However, the most compelling demonstration of CFTR-dependent ENaC inhibition has come from studies on Xenopus oocytes coexpressing both channels. Significant reduction of macroscopic amiloride-sensitive Na + current by cAMPstimulated CFTR was reported by several research groups, including one of our laboratories (Mall et al., 1996; Briel et al., 1998; Chabot et al., 1999; Jiang et al., 2000; Ji et al., 2000; Suaud et al., 2002a; Suaud et al., 2002b) . Assuming that specific protein-protein interactions were involved, the oocyte expression system was further used as a functional assay in an attempt to identify regions on CFTR or ENaC protein implicated in these interactions, but results obtained by different groups did not provide a consistent model (Schreiber et al., 1999; Jiang et al., 2000; Ji et al., 2000) . In more recent studies, when series resistance was minimized (see below), ENaC inhibition by activated CFTR was often very small (<20%) or statistically insignificant (Suaud et al., 2002a; Suaud et al., 2002b; Samaha et al., 2004; Yan et al., 2004 Konstas et al. (2003) found voltage-independent inhibition. A report by König et al. (2001) attributed inhibition to the elevation of intracellular [Cl -] , although this parameter was not measured directly in that study. In addition, a chloridedependent inactivation mechanism would require tissue-specific regulation to explain the opposing effects observed in airways and sweat glands and is in contrast to the stimulation of 22 Na + uptake by Cl -influx in ENaC/CFTR-or ENaC/ClC-0-coexpressing oocytes (Nagel et al., 2001b) .
Some recent studies did not find specific CFTR-dependent ENaC inhibition in MDCK epithelial cells or in Xenopus oocytes (Lahr et al., 2000; Nagel et al., 2001b) . In particular, Nagel et al. (2001b) proposed that in Xenopus oocytes, under certain experimental conditions, apparent CFTR-dependent reduction of amiloride-sensitive current may be artifactual, a result of excessively large series resistance leading to considerable voltage-clamp errors. Because the resulting errors grow with increasing membrane conductance, activation of CFTR will reduce the fraction of voltage acting on the membrane. As a result, ENaC current is reduced due to a smaller electrical driving force, which could be misinterpreted as inhibition (Nagel et al., 2001b ).
This conclusion was supported by Chabot et al. (2002) in a recent erratum.
The aim of the present study was to determine whether cAMP activation of CFTR downregulates ENaC in Xenopus oocytes and to identify potential sources of dissimilar findings reported by different laboratories. The effect of CFTR activation on ENaC was examined in three independent laboratories, each with a different experimental protocol. We paid special attention to minimize voltage clamp errors. Our three laboratories found no evidence of ENaC inhibition by activated CFTR if oocytes were voltage-clamped with minimal series resistance and high gain of the amplifier was used. Part of this study has been presented in preliminary form (Nagel et al., 2001a) . (Chabot et al., 1999; Nagel et al., 2001b) . Because membrane resistance (R m ) could be reduced significantly, sometimes even down to ~1 kOhm in oocytes expressing ENaC and/or CFTR (Nagel et al., 2001b; Nagel, 2004) , special care was taken to keep other resistances in series with the membrane and between intraand extracellular voltage recording electrodes as low as possible. When R m becomes comparable to the series resistance (R s ) of the recording circuit, only a fraction of the applied voltage will be experienced by the oocyte membrane, while the rest will drop across the R s . Neglecting the R s in such situations may lead to serious misinterpretation of the experimental data (Nagel et al., 2001b; Nagel, 2004) . Therefore, the components contributing to R s and the possibilities to reduce it are considered here in some detail (see also (Hodgkin et al., 1952; Taylor et al., 1960; Armstrong and Gilly, 1992; The Axon Guide, 1993) ). In principle, any resistance in series with the membrane and between the electrodes measuring voltage across the membrane contributes to R s (access resistance). Major sources to be considered are resistance of the cytoplasm, tissue covering the oocyte (e.g. the vitellin layer), the electrolyte (bath) solution, agar bridges, and Ag/AgCl electrodes. By careful design of the experiment, some of these elements may be eliminated, and resistance of others may be reduced. The remaining R s can be compensated electronically, at least partially if necessary (Moore et al., 1984) . Techniques to measure R s have been described by Binstock et al. (1975) . Generally, two electrodes, separate from the currentpassing electrode, were used for differential membrane potential measurements. by Axon. A virtual ground amplifier (VG-2A) was used to measure current. This amplifier was connected to two bath electrodes, one to pass current and one to sense voltage, virtually without passing current. In all three cases, the extracellular electrode to measure V m is placed, via an agar bridge, very close to the oocyte. The second bath electrode, used to pass current, is a Ag/AgCl wire.
Methods

Electrophysiology
Bath fluid resistance was measured as described below and was typically close to 100 Ohm, when the external voltage reference electrode (V ref ) was kept close to the oocyte (Nagel, 2004) .
This is in agreement with the calculated access resistance to a sphere of ∅ 1 mm in ND96
solution (Hille, 1992; Baumgartner et al., 1999) . However, R s may increase up to several kOhm for some commercially-available experimental chambers, which have a separate well for the bath electrode located at some distance from the oocyte (e.g. RC-10, Warner Instruments, Hamden, CT).
Bath fluid resistance measurements:
Bath fluid resistance of the recording chamber, an important part of the R s in two-electrode voltage-clamp experiments (Nagel et al., 2001b; Nagel, 2004) , could be estimated by the method described by Nagel (2004) . Briefly, in the absence of an oocyte, the two glass microelectrodes that are normally used to impale the oocyte are introduced circuit has a tendency to oscillate at high gains. The interesting point here is that an elevation of membrane conductance, e.g. CFTR activation, will increase the voltage error and decrease the driving force on total conductance. Thus, with low feedback gain, activation of the CFTR could result in an apparent decrease of amiloride-sensitive ENaC conductance, which could be misinterpreted as the result of interaction between the two channels.
Oocyte acquisition and injection. Oocyte isolation and injection procedures were described in previous publications from our laboratories (Weinreich et al., 1997; Chabot et al., 1999; Weinreich et al., 1999) . Mature female Xenopus laevis were maintained at 18-20°C with a 12-hour light-dark cycle. Oocyte clusters were surgically removed from the ovaries and torn apart with forceps in ND96 medium containing (in mmol/L) 96 NaCl, 2 KCl, 10 HEPES, 1.8 CaCl2, at pH 7.4. Denuded oocytes were obtained by collagenase digestion (type IA, 370 U/mL, Sigma)
for 2 hours at room temperature and rinsed several times in ND96 or ORi (see below). Stage 5 to 6 oocytes were selected and incubated overnight at 18°C in ND96 or ORi medium with gentamycin (50 µg/mL). Healthy oocytes were selected and injected with up to 50 nL of cRNA (5-200 ng/µL). The oocytes were incubated for 2 to 4 days after injection in ND96 or ORi medium supplemented with gentamycin and 10 µmol/L amiloride.
Solutions:
The ND96 solution contained (in mM): 96 NaCl, 2 KCl, 1 MgCl 2 , 5 Hepes, 2.5 Napyruvate, 1.8 CaCl 2 , Penicillin 40 U/ml, Streptomycin 40 µg/ml, gentamycin 50 mg/liter, pH 7.6.
The ORi solution contained (in mM): 110 mM NaCl, 5 KCl, 2 CaCl 2 , 1.8 MgCl 2 , 5 Mops, pH 7.6.
Experimental protocols
Two different experimental protocols were followed to study the effect of CFTR activation on ENaC co-expressed in oocytes. Protocol 1 (data in Figure 2 Figure 2A shows the I-V relationships of amiloride-sensitive current in oocytes expressing the α-,β-, γ-subunits of human ENaC (hENaC). It demonstrates that amiloride-sensitive, hENaCmediated current was not affected by cAMP stimulation. When the hENaC was co-expressed with the CFTR, application of cAMP-elevating cocktail to these oocytes activated a large CFTRmediated current, but had no effect on amiloride-sensitive current ( Figure 2B ). Figure 2C summarizes whole-cell ENaC-and CFTR-mediated conductances (G ENaC and G CFTR, respectively) calculated from the slope of the I-V relationships, such as those shown in A and B. Figure 2D ). This figure shows that even at G CFTR /G ENaC ratios of ~2, stimulation of CFTR had no effect on hENaC activity.
Results
CFTR fails to inhibit human and rat ENaC co-expressed in Xenopus oocytes
In an independent study, the α-, β-and γ-subunits of rat ENaC (rENaC) were expressed instead of human ENaC (Figure 3 ). In this study, a different experimental protocol was used, i.e.
oocytes coexpressing rENaC and CFTR were voltage-clamped at a fixed V m of -60 mV, and the oocyte current was recorded continuously during the entire experiment. Figure 3A gives an example of a current trace from such an experiment performed without compensating the R s of the bath fluid and the ground electrode. Elevation of intracellular cAMP by including 1 mM IBMX in the perfusate resulted in significant stimulation of CFTR-mediated current, and, under these conditions, an apparent reduction of amiloride-sensitive, ENaC-mediated current.
However, when the R s was reduced by using the virtual ground bath amplifier with two bath electrodes, no inhibition of amiloride-sensitive current was observed ( Figure 3B ). This demonstrates that apparent inhibition of the ENaC by the CFTR may inadvertently occur if the R s is not properly reduced. Figure 3C summarizes the data from several experiments, such as those in Figure 3B , showing that CFTR activation had no statistically significant effect on rENaC. Figure 3D examines this effect in oocytes expressing different CFTR/ENaC current ratios and reveals that even at ratios approaching 4, the CFTR did not inhibit rENaC. Thus, our results with hENaC and rENaC confirm the previous report by Nagel et al. (2001b) that the CFTR does not inhibit the ENaC in oocytes, if oocyte V m is properly controlled.
In a further series of voltage clamp experiments with rENaC/hCFTR-coexpressing oocytes, we examined the effect of the voltage gain on apparent ENaC conductance and its seeming "regulation" by activated CFTR. In these experiments, the actual membrane voltage was also measured, but the observed voltage deviations from the target value at the different gains (see Methods: "Other sources of voltage clamp errors") were not taken into account when calculating "apparent conductances", as is usually done by all commercial software. In addition,
we determined real conductances from the actually observed current and voltage values. Table 2 shows both apparent and real ENaC conductances before and after CFTR activation, determined at three different voltage gains. As expected, lower voltage gain leads to a decreased apparent ENaC conductance when the CFTR is activated, and this directly results from voltage clamp errors (see Methods: "Other sources of voltage clamp errors").
To demonstrate that CFTR activation modulates the amiloride-sensitive component of the V m , we measured V m under current clamp conditions (with I = 0) before and after CFTR stimulation.
Amiloride was briefly removed (to activate ENaC conductance), and corresponding shifts of V m
were measured. Figure 4A shows the voltage shift induced by amiloride removal in hCFTR/rENaC-co-expressing oocytes before and after CFTR activation. Clearly, the amilorideinduced voltage shift was much smaller, once the CFTR was activated. The effect of CFTR activation on the amiloride-sensitive voltage shift was fully reversible, as demonstrated in Figure   4B , where amiloride removal-induced voltage shift was examined first with activated CFTR and then after CFTR inactivation. The mean amiloride-sensitive voltage shift for rENaC/hCFTRcoexpressing oocytes was 35 ± 7 mV with CFTR inactive and dropped to 10 ± 5 mV after CFTR activation (n = 8). This effect was not specific for CFTR-mediated conductance, because nonspecific increase of membrane conductance introduced, e.g. by simply rupturing the oocyte membrane, also decreased the ENaC-related, amiloride-sensitive voltage shift (data not shown).
It is important to note that for each oocyte tested in these current clamp experiments, we also confirmed that ENaC conductance was not influenced by CFTR activation under voltage clamp conditions with high voltage gain and low R s . Although this might seem paradoxical at first glance, modulation of the amiloride-induced voltage shift by other conductances is in fact expected and will be explained in the Discussion.
Discussion
The hypothesis that the CFTR inhibits the ENaC has its roots in early studies before the involved channels, the CFTR and the ENaC, were identified at the molecular level. In vivo and in vitro transepithelial potential measurements on normal and CF airway epithelia detected increased amiloride sensitivity of CF tissues (Knowles et al., 1981; Knowles et al., 1983) . This was attributed to increased rates of Na absorption (hyperabsorption) by CF epithelia and seemed to explain elegantly the abnormally dehydrated mucus in CF airways (Boucher et al., 1986) . After cloning the CFTR and ENaC (Riordan et al., 1989; Canessa et al., 1993; Lingueglia et al., 1993) , it was expected that one of the functions of the CFTR was to inhibit the ENaC (Stutts et al., 1995) . Indeed, several laboratories subsequently reported direct inhibition of the ENaC by the CFTR in several experimental systems, including voltage-clamped oocytes of Xenopus laevis (Mall et al., 1996; Letz and Korbmacher, 1997; Jiang et al., 2000; Suaud et al., 2002a; Suaud et al., 2002b; Konstas et al., 2003) . Our present results demonstrate that the CFTR does not inhibit ENaC in oocytes and are, thus in direct contrast to previous reports, which used the same expression system. This could not be attributed to low expression ratios of the CFTR compared to the ENaC (Kunzelmann, 2003) , because we have examined the effect at different CFTR/ENaC conductance ratios (up to 4, absolute conductance ranges were 10 to 100 µS for the ENaC and 10 to 300 µS for the CFTR) and under widely varying conditions. Furthermore, we found no inhibitory effect with both hENaC and rENaC ( Figure 2D , Figure 3D and Nagel at al., 2001b) . It was also suggested that functional ENaC-CFTR interactions may differ between murine and human ENaC, as well as, that they could be influenced by naturally-occuring polymorphism of alpha-hENaC (Yan et al. 2004) . They found less than 35% inhibition of mENaC by activated CFTR (their Figure 1A) , only modest 20% for T663 α-hENaC and no change for A663 α-hENaC (their Figure 2) . Because in these recent experiments Yan et al. (2004) also used a virtual ground, as in our experiments, voltage-clamp errors could be avoided, if experiments were performed at high voltage gain and with low series resistance. Thus, the absence or negligible inhibition is expected and agrees with our data. Indeed, in our present study we used the same variant T663 for which Yan et al. (2004) found a modest inhibition (20%, their Fig. 2 ), whereas we found no inhibition when series resistance was fully compensated and high gain of the amplifier was used.
As our three laboratories did not observe ENaC inhibition by CFTR activation, the obvious question arises: how to reconcile our findings with those reported by other investigators? After careful examination of all the different experimental conditions, we come to the conclusion that the only reasonable explanation for such divergent results is the way the two electrode voltage clamp techniques were deployed. For example, high R s or too low feedback voltage gain could both limit the ENaC conductance measured. Because a R s problem can arise easily and inadvertently, and indeed it happened to one of us (Chabot et al., 1999; Chabot et al., 2002) , we made an effort to closely examine the problem and to find a simple method to estimate the actual R s of the recording set-up. As recently demonstrated by one of us (Nagel et al., 2001b ), the R s in the measuring circuit may simulate ENaC inhibition if the R m drops due to activation of large membrane conductance ( (Nagel et al., 2001b; Nagel, 2004) , see also Figure 3A ). This hypothesis is further strengthened by closely examining experimental data published by other laboratories.
For example, König et al. (2001) reported ENC inhibition by the CFTR and intracellular Cl -.
However, under their experimental conditions, the ENaC was not only inhibited by activation of a completely unrelated chloride channel, ClC-0, but also by permeabilization of the membrane with amphotericin. Thus, all maneuvers that increased membrane conductance -expression of the CFTR or ClC-0 or amphotericin-induced membrane permeabilization -resulted in apparent ENaC inhibition. To us, these data suggest that the R s likely limits the measurable conductance and, in this way, simulates ENaC "inhibition". In addition, apparent ENaC inhibition could result when too small gain in the voltage feedback loop is used, once additional conductance is activated (see Table 2 ). Other groups recently studied ENaC-CFTR interactions in oocytes that were voltage-clamped with a presumably low R s . However, their actual data show that cAMP stimulation of wild type CFTR had a very small (<20% ) or statistically non-significant effect on the ENaC (Suaud et al., 2002a; Suaud et al., 2002b; Yan et al., 2004) . Such results are expected if oocytes were clamped with minimal R s and, thus, are consistent with our interpretation.
The assumption that the apparent interaction between the CFTR and ENaC is due to voltage clamp errors explains a variety of observations reported in the literature. First, it explains why the CFTR seems to interact with almost all other electrogenic transport systems -channels as well as transporters. Second, it explains that the degree of inhibition depends on the expression level, i.e. the CFTR-mediated conductance. Third, it also explains the results of mutation experiments if one takes into account that the conductances induced by mutated CFTR channels are much lower (Mall et al., 1996; Briel et al., 1998; Schreiber et al., 1999) . And fourth, it explains why the reduction of Cl -concentration, and therefore membrane conductance, reduces apparent interaction between the CFTR and ENaC.
It might be also interesting to review the early findings of elevated amiloride-induced voltage shifts in CF tissues which ultimately led to the notion of increased sodium absorption in CF. In fact, we also observed similar effects in CFTR/ENaC-coexpressing oocytes. As Figure 4 shows, the amiloride-induced voltage shift is smaller once the CFTR is activated. It is often assumed that such reduction of voltage shift hints of CFTR-dependent inhibition of amiloridesensitive sodium current. However, this is not necessarily the case and alternative explanations are possible. In the following example, we will consider amiloride-induced voltage shifts in oocytes expressing the CFTR and ENaC. V m can be well described by the Goldmann-Hodgkin- ] o = 5 mM. As an illustration, let us assume that P K = 0.01 P Na and that in the absence of CFTR stimulation, the residual P Cl = 0.01 P Na , while after CFTR activation, P Cl = 3 P Na . Also, let us assume that in the presence of amiloride, residual P Na (amil) = 0.01 P Na and then calculate V m for different experimental situations. With the CFTR inactive and amiloride present, V m = -13.5 mV, while upon amiloride removal, it will increase to +31.4 mV. After CFTR stimulation and in the presence of amiloride, V m will be -25.2 mV, whereas with active CFTR and ENaC, the V m will be -12.2 mV.
Thus, the amiloride-induced voltage shift when the CFTR is inactive will be ~45 mV, while it will be much smaller after CFTR activation: 13 mV (see Figure 5 ). Indeed, this confirms qualitatively what we observed in voltage measurements on CFTR/ENaC-coexpressing oocytes (Figure 4) . The experimentally-observed values are slightly different because the actual conductances and intracellular ion concentrations may be somewhat different from those used in our simple example. Not surprisingly, activation of a chloride conductance, which is not mediated by the CFTR, may also lead to a reduced amiloride-induced voltage shift in transepithelial voltage measurements, without the need to invoke "regulatory interactions" as is done often (e.g. Schreiber et al., 2003) . Of course, this argument does not apply to careful conductance estimates derived from application of current injections. Conductance measurements by current injections can, under certain conditions, accurately reflect amiloridesensitive sodium conductance. Such conductance measurements will, however, only yield reliable results if residual conductance is not overwhelming and if R s is not too large. It is also important to stress that our study is limited to only one expression system, amphibian oocytes. It may well be that CFTR-ENaC regulatory interactions cannot be reproduced in oocytes because some factor(s), which are required for such interactions, are missing in these cells. Thus, it will be critical to extend our study to other cellular systems, while ensuring optimal recording conditions.
In summary, the results from our three independent laboratories univocally demonstrated the absence of ENaC inhibition by the CFTR in Xenopus oocytes, when R s of the recording circuitry was low (~100 ohm). We suggest that the inhibitory effects previously reported in the literature could be attributed to either unfavorable large R s or insufficient voltage gain or both, resulting in apparent reduction of ENaC conductance. Lessons from the oocyte expression system argue for careful re-examination of other in vitro experimental systems in which CFTRENaC regulatory interactions are studied, especially in whole cell patch clamp experiments,
where it is known that access resistance has to be monitored carefully (Armstrong and Gilly, 1992) . A. Example of a current trace recorded at -60 mV from an oocyte co-expressing α-, β-and γ-rENaC and hCFTR recorded with a single bath electrode (see Fig. 1 Figure 1 
